These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22358380)

  • 21. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H; Jiang P; Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hexosoaminidase gene expression in cholesteatoma in adults].
    Rutkowska J; Olszewska E; Waniewska E; Czechowska S; Kowalczuk O; Borawska M; Zukowska M; Markiewicz R; Rogowski M
    Otolaryngol Pol; 2009; 63(6):490-5. PubMed ID: 20198983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation characteristics of cholesteatoma epithelium determined by expression of transglutaminase isoenzymes.
    Chang CS; Jun BH; Song KY; Kim IG
    J Korean Med Sci; 1999 Dec; 14(6):665-70. PubMed ID: 10642946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
    Koizumi H; Kawaguchi R; Ohkubo JI; Ikezaki S; Kitamura T; Hohchi N; Hashida K; Suzuki H
    Clin Otolaryngol; 2017 Apr; 42(2):252-262. PubMed ID: 27390311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
    Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
    Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
    Kojima H; Shiwa M; Kamide Y; Moriyama H
    Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cyclic hydrodynamic pressure-induced proliferation of human bladder smooth muscle through Ras-related C3 botulinum toxin substrate 1, mitogen-activated protein kinase kinase 1/2 and extracellular regulated protein kinases 1/2.
    Wu T; Chen L; Wei T; Wang Y; Xu F; Wang K
    Int J Urol; 2012 Sep; 19(9):867-74. PubMed ID: 22574733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats.
    Eshaghian A; Khodarahmi A; Safari F; Binesh F; Moradi A
    Br J Nutr; 2018 Aug; 120(4):393-403. PubMed ID: 29880071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
    Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
    Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
    Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and significance of PDK1 and NF-κB in the middle ear cholesteatoma].
    Du L; Xie YD; Liu M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(10):770-773. PubMed ID: 29798050
    [No Abstract]   [Full Text] [Related]  

  • 34. Psoriasin (S100A7), an antimicrobial peptide, is increased in human middle ear cholesteatoma.
    Kim KH; Cho JG; Song JJ; Woo JS; Lee HM; Jung HH; Hwang SJ; Chae S
    Acta Otolaryngol; 2009 Oct; 129(10):1067-71. PubMed ID: 19707901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of PTEN and phosphorylated Akt in human cholesteatoma epithelium.
    Yune TY; Byun JY
    Acta Otolaryngol; 2009 May; 129(5):501-6. PubMed ID: 18615333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
    Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
    Liu D; Ma X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway.
    Cheng H; Wang W; Wang G; Wang A; Du L; Lou W
    Med Sci Monit; 2018 Feb; 24():768-781. PubMed ID: 29410394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear.
    Ishibashi T; Shinogami M; Kaga K; Fukaya T
    Acta Otolaryngol; 1997 Sep; 117(5):714-8. PubMed ID: 9349868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.